Skip to main content

Table 3 Surgery rates and factors associated with receiving surgery by topography

From: Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data

Variable

C15 Surgical Rate (per 100)

aOR#(95%CI)

C15&C160 Surgical rate (per 100)

aOR (95% CI)#

Age at diagnosis (years)

    

<60

25.0

8.96 (5.63-14.3)*

28.4

8.12 (5.64-11.7)*

60–69

23.2

9.85 (6.25-15.5)*

26.8

8.48 (5.94-12.1)*

70–79

11.1

3.99 (2.52-6.32)*

15.4

4.20 (2.94-6.00)*

80+

3.1

Referent

3.9

Referent

Gender

    

Female

10.2

Referent

11.3

Referent

Male

16.8

1.04 (0.78-1.38)

21.2

1.31 (1.05-1.64)*

Country of Birth

    

Australia

13.8

Referent

17.9

Referent

Other

16.5

0.90 (0.70-1.16)

19.1

0.76 (0.62-0.92)*

Histology group

    

SCC

11.4

0.40 (0.31-0.52)*

11.7

0.41 (0.32-0.51)*

Adenocarcinomas

20.1

Referent

23.6

Referent

Other

3.8

0.28 (0.17-0.48)*

5.9

0.36 (0.24-0.53)*

Degree of Spread

    

Localised

15.3

6.06 (4.06-9.06)*

18.6

5.50 (4.08-7.41)*

Regional

33.5

12.34 (8.22-18.52)*

38.1

10.29 (7.67-13.79)*

Distant

6.1

Referent

6.4

Referent

Unknown

5.0

2.38 (1.42-3.98)*

5.5

1.71 (1.14-2.56)*

Tumour location

    

Upper

5.8

0.22 (0.12-0.39)

5.8

0.22 (0.13-0.40)

Mid

10.9

0.51 (0.34-0.76)

10.9

0.52 (0.35-0.77)

Distal

21.5

Referent

21.5 26.4

Referent 1.10 (0.88-1.36)

Charlson comorbidity

    

0

11.4

Referent

14.1

Referent

1,2

9.7

0.52 (0.32-0.83)*

11.9

0.56 (0.39-0.80)*

3+

0

-

5.0

0.25 (0.06-1.14)

Hospital admission

    

Private co-located

43.1

Referent

46.5

Referent

Private non co-located

4.4

0.06 (0.04-0.10)*

6.2

0.07 (0.05-0.10)*

Public co-located

34.0

0.78 (0.53-1.16)

37.8

0.80 (0.59-1.08)

Public non co-located

20.6

0.26 (0.16-0.42)*

26.5

0.26 (0.18-0.38)*

Hospital area service

    

Area 1

18.1

2.30 (1.38-3.84)*

23.6

2.99 (2.03-4.39)*

Area 2

16.2

0.73 (0.48-1.09)

19.4

0.80 (0.59-1.09)

Area 3

25.8

Referent

28.6

Referent

Area 4

19.6

1.29 (0.86-1.93)

23.8

1.58 (1.16-2.17)*

Area 5

12.2

1.71 (0.99-2.97)

16.5

1.92 (1.27-2.90)*

Area 6

3.5

0.82 (0.38-1.77)

4.6

0.88 (0.49-1.56)

Area 7

5.1

0.71 (0.34-1.47)

8.2

0.98 (0.59-1.65)

Area 8

0.0

-

0.0

-

  1. # Adjusted for age-group, gender, histology, country of birth, histology, degree-of-spread, tumour location, hospital admitted, area of service, Charlson comorbidity index.
  2. * Significant at P<0.05 (two-tailed) level.